Neuropeptide Y and Sympathovagal Balance

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 5, 2018

Primary Completion Date

July 18, 2018

Study Completion Date

April 15, 2019

Conditions
Physical ActivitySympathetic Nervous SystemSecretion; Catecholamine
Interventions
DRUG

Saxagliptin 5mg

Randomised study: session 1 the volunteer will receive either saxagliptin or placebo. Session 2 the volunteer will receive the placebo or saxagliptin

DRUG

Placebo oral capsule

Randomised study: session 1 the volunteer will receive either saxagliptin or placebo. Session 2 the volunteer will receive the placebo or saxagliptin

OTHER

ergometric test in healthy volunteers

The volunteers will undergo an ergometric test in each session

Trial Locations (1)

1011

Service de Néphrologie, Lausanne

All Listed Sponsors
collaborator

grégoire wuerzner

UNKNOWN

collaborator

grégoire millet

UNKNOWN

collaborator

Nicolas Bourdillon

UNKNOWN

collaborator

Philippe Eugster

UNKNOWN

lead

Eric Grouzmann

OTHER

NCT03933787 - Neuropeptide Y and Sympathovagal Balance | Biotech Hunter | Biotech Hunter